Development of a Skin-life Care Platform for patients with advanced non-small cell lung cancer, who undergo molecular targeted therapy
| Project/Area Number |
24659980
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Clinical nursing
|
|---|
| Research Institution | Asahikawa Medical College |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HAMADA Tamami 旭川医科大学, 医学部, 教授 (00374273)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
KOMATSU Hiroko 慶応義塾大学, 看護医療学部, 教授 (60158300)
MATSUBARA Kazuo 京都大学, 医学(系)研究科(研究院), 教授 (20127533)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2013: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 分子標的薬治療 / 進行非小細胞肺がん / 皮膚障害 / スキンケア / スキンライフケア / スキンライフ / 皮膚障害の体験 |
|---|
| Outline of Final Research Achievements |
We conducted this study to develop a “Skin-life Support Platform (strategy) for NSCLC” for patients with advanced non-small cell lung cancer (NSCLC) who undergo molecular targeted therapy.
As a result we developed a clearer understanding of the fears patients with advanced NSCLC harbor about skin life and that it leads to a lower Quality of Life (QOL), these fears pose a threat to willingness to continuing the molecular targeted therapy. Findings showed that it is necessary to propose effective skin care based on the evidence from the “Skin-life Support Platform for NSCLC”, and develop nursing practices to apply with patients.
|
Report
(4 results)
Research Products
(4 results)
